Skip to content

Does combined doxycycline and autologous blood patch more effective autologous blood patch alone for management of persistent air leak in patients with secondary spontaneous pneumothorax : A randomized control trial

Efficacy of combined doxycycline and autologous blood patch versus autologous blood patch alone for management of persistent air leak in patients with secondary spontaneous pneumothorax : A randomized control trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202505753650802
Enrollment
90
Registered
2025-05-06
Start date
2025-01-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory

Interventions

Autologous blood patch pleurodesis.
autologous blood patch pleurodesis with doxycycline

Sponsors

king Saud medical city
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1- Adult patients of both sexes Age =18 2- Patients with secondary spontaneous pneumothorax and persistent air leak =7 days (grade 1-2). Air leak was graded based on Cerfolio classification of air leak

Exclusion criteria

Exclusion criteria: 1- Previous history of ipsilateral pleurodesis. 2- Traumatic or primary spontaneous pneumothorax. 3- Patients with underlying haematological disorders- coagulopathies. 4- Known case of allergy to doxycycline 5- Patients with active pulmonary infection

Design outcomes

Primary

MeasureTime frame
A-Primary outcomes Rate of complete cessation of air leak between both groups. Leak until the seventh day of procedure was considered as success

Secondary

MeasureTime frame
B- Secondary outcomes • Length of hospital stay • Post-procedure complications including fever, tachycardia, emphysema, dyspnea and pain scoring using the numeric pain rating scale

Countries

Egypt, Saudi Arabia

Contacts

Public ContactAYMAN YOUSEF

consultant thoracic surgery

abusitte@yahoo.com00966500667132

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026